1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Mn-PyC3A: new trials by email Literature Review of Mn-PyC3A trials Research Report on Mn-PyC3A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Meningioma (1) · Multiple Sclerosis (1) · Neoplasms (1) · Neurilemmoma (1) · Neurofibroma (1) · Neuroinflammatory Diseases (1) · Neuroma, Acoustic (1)
Reveal Pharmaceuticals Inc. (1)
United States (1)
R44CA261240 (1)